A 68-year-old man with myasthenia gravis presents to the emergency department with acute worsening of ptosis, diplopia, and generalized muscle weakness. He is on pyridostigmine 60 mg QID. Vital signs: BP 140/88 mmHg, HR 92/min, RR 18/min, SpO₂ 94% on room air. On examination, he has increased salivation, lacrimation, and mild bronchospasm. Which is the most appropriate immediate next step in management?

Explanation

## Clinical Scenario Analysis The patient presents with signs of **cholinergic crisis** — a life-threatening complication of anticholinesterase overdose or accumulation. The key clinical clues are: - **Muscarinic signs**: increased salivation, lacrimation, bronchospasm ("SLUDGE" syndrome) - **Nicotinic signs**: generalized muscle weakness, ptosis, diplopia - **Temporal context**: acute worsening despite being on pyridostigmine ## Pathophysiology of Cholinergic Crisis **Key Point:** Cholinergic crisis occurs when excess acetylcholine accumulates at the neuromuscular junction and autonomic synapses due to: 1. Pyridostigmine overdose or accumulation (renal impairment, drug interactions) 2. Inability to metabolize the drug adequately 3. Paradoxical worsening of weakness despite anticholinesterase therapy ## Differential: Myasthenic vs. Cholinergic Crisis | Feature | Myasthenic Crisis | Cholinergic Crisis | |---------|-------------------|--------------------| | **Salivation/Lacrimation** | Absent | Present (SLUDGE) | | **Bronchospasm** | Absent | Present | | **Pupil size** | Normal | Miosis | | **Muscle fasciculations** | Absent | May be present | | **Response to anticholinesterase** | Improves | Worsens | | **Cause** | Insufficient drug | Excess drug | ## Management Algorithm ```mermaid flowchart TD A[Acute weakness + SLUDGE signs in MG patient]:::outcome --> B{Myasthenic or Cholinergic Crisis?}:::decision B -->|Cholinergic signs present| C[STOP anticholinesterase immediately]:::action C --> D[Administer atropine 0.5-1 mg IV]:::action D --> E[Atropine blocks muscarinic effects]:::outcome E --> F[Prepare for mechanical ventilation]:::action F --> G[Supportive care + monitoring]:::action B -->|Myasthenic signs only| H[Increase anticholinesterase dose]:::action ``` **High-Yield:** In cholinergic crisis, **atropine is the antidote**. It blocks muscarinic receptors and rapidly reverses salivation, bronchospasm, and bradycardia. Nicotinic effects (muscle weakness) do NOT respond to atropine and require supportive care (mechanical ventilation if respiratory muscles are involved). **Clinical Pearl:** The **edrophonium test is contraindicated** in suspected cholinergic crisis because it would worsen the condition by further increasing acetylcholine levels. It is only used when the diagnosis is uncertain and myasthenic crisis is suspected. **Warning:** Do NOT increase the pyridostigmine dose — this will worsen the crisis. The drug must be stopped immediately. ## Immediate Actions 1. **Discontinue pyridostigmine** immediately 2. **Administer atropine 0.5–1 mg IV** (may repeat every 5–10 minutes if needed) 3. **Prepare for mechanical ventilation** — respiratory failure is the primary life threat 4. **Supportive care**: oxygen, cardiac monitoring, airway management 5. **Pralidoxime is NOT indicated** — it is used for organophosphate poisoning, not anticholinesterase drug toxicity **Key Point:** Atropine alone is sufficient for cholinergic crisis management. Pralidoxime (an oxime) reactivates acetylcholinesterase and is reserved for organophosphate/carbamate poisoning, where the enzyme is irreversibly phosphorylated.